Health execs focus IT spending on ROI as AI adoption matures
A new Bain and KLAS survey finds nearly all providers and payers plan to invest in health IT, with measurable returns on AI becoming a key condition for continued spending.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
Cat Tumor Genetics Could Guide Cancer Care for Both Species
A large genetic study of feline cancers found striking molecular parallels with human tumors, opening new possibilities for precision treatments.
Why Rheumatoid Arthritis Pain Persists When Inflammation Eases
Depression, poor sleep, obesity, smoking, and chronic pain may keep rheumatoid arthritis symptoms going even after inflammation improves, researchers report.
Newer Blood Thinners Cut Serious Events by 69% in Atrial Fibrillation
A randomized trial found that direct oral anticoagulants reduced serious cardiovascular events in atrial fibrillation patients at intermediate stroke risk, without increasing major bleeding.
SAFE Score Best for Predicting Cirrhosis in Steatotic Liver Disease
Among nine risk tools tested in a large VA cohort, the SAFE score offered the greatest net benefit for 10-year cirrhosis risk, though none adequately predicted liver cancer.
Backup cysteine-making pathway found in mammalian cells
A newly discovered cellular backup route for making cysteine may help explain drug resistance and open new angles for cancer treatment.
Trump cancels nearly $1B in approved spending, hitting HHS programs
The administration's rare 'pocket rescission' targets refugee health services and HHS research grants, drawing bipartisan criticism.
AMA Backs Classifying Myopia as a Disease to Expand Children's Care
A new American Medical Association resolution supports treating nearsightedness as a disease, a step eye specialists say could improve screening, insurance coverage, and access to treatments that slow progression in children.
Radiology practices are becoming AI developers, blurring clinical and tech work
Radiology groups are developing and deploying their own AI tools, turning clinical practice into a testing ground for the technology.
Rare flavoalkaloids found in cannabis leaves for first time
A new analysis of discarded cannabis leaves uncovered 25 previously unreported phenolic compounds, including rare flavoalkaloids, suggesting overlooked biomedical potential.
Regulatory Tracker Covers FDA Updates for Merck's Winrevair and Nuvation's Ibtrozi
A Fierce Pharma tracker rounds up regulatory progress for Merck's pulmonary hypertension drug and Nuvation's cancer candidate.
FDA Staff Raise No Major Concerns About Galleri Cancer Test
Regulatory reviewers found no major safety or accuracy problems with the Galleri multicancer early detection blood test ahead of an FDA advisory committee meeting.
Oz: AI will drive up healthcare costs before savings materialize
CMS chief Mehmet Oz says AI adoption will initially inflate medical billing costs, with long-term relief tied to accountable care models.
Breast cancer screening overdiagnosis may be below 5%, reanalysis finds
A new analysis of all major randomized trials suggests that overdiagnosis from mammography is far less common than previously thought, potentially reassuring women about screening benefits.
Tirzepatide activates calorie-burning brown fat in obese mice
A mouse study suggests the obesity drug tirzepatide may improve metabolism by directly activating brown adipose tissue, beyond its known appetite-suppressing effects.
Democrats Question RFK Jr. Over Ethics Agreement Change on Vaccine Litigation Fees
Senators say Health Secretary Robert F. Kennedy Jr. quietly changed his ethics disclosure after confirmation, transferring a litigation stake to his former law firm instead of his son.
Scented cleaners create lung-penetrating nanoparticles indoors
New research shows fragrance compounds in cleaning products react with indoor ozone to form ultrafine particles that may rival traffic pollution exposure.
Defensive Medicine Is a Hidden Curriculum for Medical Students
Two medical students argue that fear of lawsuits teaches trainees a second, conflicting syllabus alongside evidence-based medicine.